People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eargo, Inc. | — | Other Health Care | Series C | $187.4M | $1.9B | 2020 |
| Endogenex, Inc. | — | Other Health Care | Series C | $122.0M | $576.1M | 2018 |
| Encore Dermatology, Inc. | — | Other Health Care | Series B | $89.6M | $729.9M | 2019 |
| RxSight, Inc. | — | Other Health Care | Series C | $76.4M | $1.1B | 2017 |
| Sydnexis, Inc. | — | Other | Series C | $72.3M | $133.2M | 2024 |
| Venus Concept Ltd. | — | Other Health Care | Series B | $66.5M | $311.3M | 2017 |
| Pixeloptics Inc | — | Other Technology | Series B | $65.1M | $106.6M | 2011 |
| Facet Solutions Inc | — | Other Health Care | Series A | $13.0M | $42.8M | 2009 |
| Sympara Medical, Inc. | — | Other | Series A | $12.8M | $45.6M | 2014 |
Juliet Bakker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Juliet Bakker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Geoff Pardo | 2 | 6 |
| Scott Barry | 2 | 4 |
| Michael Brown | 1 | 34 |
| Garheng Kong | 1 | 16 |
| William Link | 1 | 11 |
| Peter Bisgaard | 1 | 9 |
| Adele Oliva | 1 | 9 |
| Ryan Schwarz | 1 | 7 |
| John Deedrick | 1 | 7 |
| Ross Jaffe | 1 | 7 |
| David Wu | 1 | 7 |
| Bruce Robertson | 1 | 7 |
| James Eadie | 1 | 6 |
| Gary J. Kurtzman | 1 | 6 |
| Jack Kavanaugh | 1 | 6 |
| William Kelley | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Jay K. Hachigian | 1 | 5 |
| J. Andy Corley | 1 | 5 |
| Joseph Mandato | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.